September 13, 2024
PENSACOLA, FL – Catalyst Healthcare Real Estate (Catalyst), a full-service healthcare real estate development and investment firm, is excited to welcome Eric Fischer as the new Chief Development Officer. Eric’s significant experience and development expertise will be key in accelerating Catalyst’s mission and driving innovation.
"Eric brings great insight, knowledge, and guidance across all facets of Catalyst,” said Chad Henderson, Founder and CEO of Catalyst. "His extensive experience in healthcare and life sciences real estate development will be instrumental in strategically aligning our projects and partnerships."
Prior to joining Catalyst, Eric was a Principal, Managing Director, as well as the National Healthcare Product Specialist for Trammell Crow Company ("TCC"). Eric’s tenure at TCC spanned nearly two decades. TCC is a multinational development firm that employs over 600 professionals in 27 major cities throughout the United States and Europe. During his time at TCC, Eric directly oversaw over $4.7 billion in projects, totaling more than 6 million square feet throughout the Mid-Atlantic region. Currently, Eric serves as Chairman Emeritus for the Urban Land Institute’s Healthcare & Life Sciences Council, as well as numerous Board and civic groups.
In addition to welcoming Eric to the team, Catalyst is pleased to announce two significant promotions. Alex Stacy, who has dedicated six years of unwavering dedication to advancing Catalyst's vision as Chief Operating Officer, has been promoted to President and Chief Operating Officer. Alex Lincoln, recognized for his tenacity in driving business growth, is now Chief Growth Officer. Both leaders will play vital roles in continuing Catalyst’s growth and innovation.
As Catalyst continues to expand, each of these leaders as well as our entire team at Catalyst will play a key role in advancing the company’s mission and vision, further building on Catalyst’s portfolio, and accelerating its growth.
###
ABOUT CATALYST HEALTHCARE REAL ESTATE
Catalyst is a national, healthcare real estate development and investment firm. Our platform of integrated real estate deliverables is specifically designed for the ever-evolving landscape of healthcare real estate. Our team seeks to positively impact healthcare with strategic investment in development, acquisition, and strategy services. For more information, please visit catalysthre.com.
Contact:
Bella Costa bcosta@catalysthre.com | 252-675-3465
Click here to read the additional HREI feature article.